Sanguine Enterprises Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-12-2024
- Paid Up Capital ₹ 4.72 M
as on 16-12-2024
- Company Age 22 Year, 30 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 6.30%
(FY 2022)
- Profit 5.08%
(FY 2022)
- Ebitda -19.21%
(FY 2022)
- Net Worth 11.13%
(FY 2022)
- Total Assets -13.10%
(FY 2022)
About Sanguine Enterprises
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.72 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Dhody, Shubhra Dhody, Gayatri Dhody, and One other member serve as directors at the Company.
- CIN/LLPIN
U45201DL2002PTC118127
- Company No.
118127
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sanguine Enterprises?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Dhody  | Director | 20-Dec-2002 | Current |
| Shubhra Dhody | Director | 20-Dec-2002 | Current |
| Gayatri Dhody | Director | 20-Jan-2022 | Current |
| Shalini Dhody | Director | 20-Jan-2022 | Current |
Financial Performance of Sanguine Enterprises.
Sanguine Enterprises Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.3% increase. The company also saw a slight improvement in profitability, with a 5.08% increase in profit. The company's net worth Soared by an impressive increase of 11.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanguine Enterprises?
In 2019, Sanguine Enterprises had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
S S Enterprises Private LimitedActive 28 years 2 monthsSanjay Dhody, Shubhra Dhody and 2 more are mutual person
- Dhody Products Private LimitedActive 34 years 1 month
Sanjay Dhody, Shubhra Dhody and 2 more are mutual person
- Vairaj Enterprises Private LimitedActive 16 years 3 months
Gayatri Dhody and Shalini Dhody are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanguine Enterprises?
Unlock and access historical data on people associated with Sanguine Enterprises, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanguine Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanguine Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
